SPIRIT IV A Prospective, Randomized Trial Comparing an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease.
MINIMASTER: PREVENZIONE DELLE RECIDIVE E ADERENZA ALLE TERAPIE GLICEMIA A DIGIUNO, POST-PRANDIALE O HbA1c: COME IMPOSTARE IL CONTROLLO A LUNGO TERMINE.
What’s New in Diabetes Maeve C. Durkan MBBS, FACP, Mmed.Ed Consultant in Diabetes, Endocrinology & Metabolism.
The Art and Science of Insulin Thomas Repas D.O. Diabetes, Endocrinology and Nutrition Center, Affinity Medical Group, Neenah, Wisconsin Member, Inpatient.
IMPLICATIONS OF UKPDS GSK Advisory Board 24 May 2003 Dr. J. R. Conway.
Issues in Diabetes Care Academic Half-day February 2002 D. Hunt.
Why Patients are Reluctant to Start Insulin, and What to Do About it William H. Polonsky, PhD, CDE January 30, 2009 [email protected].
FDA Endocrinologic and Metabolic Drugs Advisory Committee 1st June 2008 Rury Holman Clinical outcomes with anti-diabetic drugs: What we already know.
Metabolic Alterations in Children with Obstructive Sleep Apnea Bharat Bhushan, PhD Department of Surgery Division of Otolaryngology-Head and Neck Surgery.
Issues in Diabetes Care
What’s New in Diabetes
